Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara A Dunn

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Current Opinion in Otolaryngology & Head and Neck Surgery|December 20, 2023
Oncology for the rhinologistKenric Tam, Lara A Dunn, Marc A Cohen
Oral Oncology|October 26, 2016
Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinomaShrujal S Baxi, Lara A Dunn, Barbara A Burtness
JAMA|December 15, 2025
Head and Neck Cancer: A ReviewLara A Dunn, Alan L Ho, David G Pfister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Reply to B. O'Sullivan et AlDavid G Pfister, Shrujal S Baxi, Lara A Dunn, et al.
Oral Oncology|July 6, 2016
Unmet needs for patients with salivary gland cancerLara A Dunn, Alan L Ho, Scott A Laurie, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2022
Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future ConsiderationsPablo Nenclares, Antonio Rullan, Kenric Tam, et al.
Head & Neck|October 1, 2017
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancerLara A Dunn, Matthew G Fury, Eric J Sherman, et al.
OTO Open|January 21, 2021
Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun BeltStephanie Flukes, Sallie Long, Shivangi Lohia, et al.
Cell Reports. Medicine|December 2, 2025
Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancerCaineng Cao, Eric J Sherman, Nadeem Riaz, et al.
The Lancet. Oncology|February 5, 2026
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort studyCaineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Current Opinion in Otolaryngology & Head and Neck Surgery|December 20, 2023
Oncology for the rhinologistKenric Tam, Lara A Dunn, Marc A Cohen
Oral Oncology|October 26, 2016
Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinomaShrujal S Baxi, Lara A Dunn, Barbara A Burtness
JAMA|December 15, 2025
Head and Neck Cancer: A ReviewLara A Dunn, Alan L Ho, David G Pfister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Reply to B. O'Sullivan et AlDavid G Pfister, Shrujal S Baxi, Lara A Dunn, et al.
Oral Oncology|July 6, 2016
Unmet needs for patients with salivary gland cancerLara A Dunn, Alan L Ho, Scott A Laurie, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 6, 2022
Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future ConsiderationsPablo Nenclares, Antonio Rullan, Kenric Tam, et al.
Head & Neck|October 1, 2017
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancerLara A Dunn, Matthew G Fury, Eric J Sherman, et al.
OTO Open|January 21, 2021
Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun BeltStephanie Flukes, Sallie Long, Shivangi Lohia, et al.
Cell Reports. Medicine|December 2, 2025
Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancerCaineng Cao, Eric J Sherman, Nadeem Riaz, et al.
The Lancet. Oncology|February 5, 2026
Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort studyCaineng Cao, Eric J Sherman, Nadeem Riaz, et al.
Pageof 5